Global Neurovascular Devices Market Size Study & Forecast, by Type, by Application, End User and Regional Forecasts 2025-2035

Description

The Global Neurovascular Devices Market is valued at approximately USD 3.32 billion in 2024 and is projected to expand at a healthy CAGR of 6.90% during the forecast period of 2025-2035, with historical benchmarks spanning 2023 and 2024 and 2024 designated as the base year for estimation. Neurovascular devices are specialized medical technologies engineered to diagnose, treat, and manage disorders affecting the blood vessels of the brain, including strokes, aneurysms, and vascular malformations. These devices play a decisive role in minimally invasive neurosurgical interventions, enabling clinicians to restore blood flow, prevent hemorrhagic events, and improve patient outcomes while reducing procedural risks and recovery times. The market's growth trajectory is being shaped by rising neurological disease prevalence, aging populations, and continuous advancements in endovascular treatment techniques.

An escalating global burden of ischemic strokes and cerebral aneurysms has significantly stepped up demand for neurovascular interventions, thereby pulling through the adoption of advanced devices. Healthcare systems are increasingly shifting toward minimally invasive procedures to lower hospitalization costs and enhance clinical efficiency, which in turn is fueling investment in next-generation neurovascular technologies. Furthermore, improved diagnostic imaging, growing awareness around early stroke management, and expanding access to specialized care centers are opening new pathways for market expansion. Despite these tailwinds, high device costs and stringent regulatory approval processes remain notable barriers, particularly in developing healthcare economies, across the forecast period of 2025-2035.

The detailed segments and sub-segments included in the report are:

By Type:

Neurothrombectomy Devices
Embolization Devices
Angioplasty Devices

By Application:

Ischemic Stroke
Aneurysm
Stenosis
Arteriovenous Malformations (AVMs)

By End User:

Hospitals and Specialty Clinics
Ambulatory Care Centers
Other End Users

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Neurothrombectomy devices are expected to dominate the Global Neurovascular Devices Market, accounting for the largest share throughout the forecast horizon. This dominance is primarily attributed to their critical role in acute ischemic stroke management, where rapid clot retrieval can dramatically improve survival rates and neurological outcomes. As stroke care protocols increasingly emphasize early intervention and mechanical thrombectomy adoption widens across hospitals, demand for these devices continues to scale up. Embolization and angioplasty devices, while essential in complex vascular interventions, are witnessing comparatively steady yet slower growth.

From a revenue contribution standpoint, ischemic stroke applications currently lead the market, driven by the rising incidence of stroke globally and the growing availability of advanced endovascular treatment options. Hospitals and specialty clinics are investing heavily in neurovascular infrastructure to handle increasing emergency caseloads, thereby reinforcing revenue generation from stroke-related interventions. Aneurysm treatment follows closely, supported by technological refinements in embolization materials and delivery systems, while applications addressing stenosis and AVMs continue to gain traction as diagnostic capabilities improve.

North America held a dominant position in the Global Neurovascular Devices Market in 2024, supported by a well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong reimbursement frameworks for neurointerventional procedures. Europe represents another significant market, driven by increasing stroke awareness programs and favorable clinical research environments. Asia Pacific is anticipated to witness the fastest growth over the forecast period, fueled by rising healthcare expenditure, improving access to specialized neurological care, and a rapidly growing patient pool in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as growth markets as investments in healthcare modernization continue to gather pace.

Major market players included in this report are:

Medtronic plc
Stryker Corporation
Boston Scientific Corporation
Johnson & Johnson (Cerenovus)
Terumo Corporation
Penumbra, Inc.
MicroVention, Inc.
Cook Medical
Merit Medical Systems, Inc.
Integra LifeSciences Holdings Corporation
Balt Group
Rapid Medical
Phenox GmbH
W. L. Gore & Associates, Inc.
Lepu Medical Technology Co., Ltd.

Global Neurovascular Devices Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes across various segments and countries in recent years and to forecast their evolution over the coming decade. The report integrates qualitative insights with quantitative analysis to examine the drivers, restraints, and opportunities shaping the Global Neurovascular Devices Market. It also delivers a comprehensive assessment of the competitive landscape, detailing product portfolios, strategic initiatives, and innovation pipelines of key players, while highlighting attractive micro-markets where stakeholders can channel investments for sustained long-term growth.

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of the geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Neurovascular Devices Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Neurovascular Devices Market Forces Analysis

3.1. Market Forces Shaping The Global Neurovascular Devices Market (2025-2035)
3.2. Drivers
- 3.2.1. rising neurological disease prevalence
- 3.2.2. Increasing Geriatric Population
3.3. Restraints
- 3.3.1. high device costs and stringent regulatory approval
3.4. Opportunities
- 3.4.1. Growing adoption of advanced devices

Chapter 4. Global Neurovascular Devices Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2025-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Neurovascular Devices Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Global Neurovascular Devices Market Performance - Potential Analysis (2025)
5.3. Neurothrombectomy Devices
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Embolization Devices
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Angioplasty Devices
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Neurovascular Devices Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Neurovascular Devices Market Performance - Potential Analysis (2025)
6.3. Ischemic Stroke
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Aneurysm
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Stenosis
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Arteriovenous Malformations (AVMs)
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 6.6.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Neurovascular Devices Market Size & Forecasts by End User 2025-2035

7.1. Market Overview
7.2. Global Neurovascular Devices Market Performance - Potential Analysis (2025)
7.3. Hospitals and Specialty Clinics
- 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 7.3.2. Market size analysis, by region, 2025-2035
7.4. Ambulatory Care Centers
- 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 7.4.2. Market size analysis, by region, 2025-2035
7.5. Other End Users
- 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2025-2035
- 7.5.2. Market size analysis, by region, 2025-2035

Chapter 8. Global Neurovascular Devices Market Size & Forecasts by Region 2025-2035

8.1. Growth Neurovascular Devices Market, Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America Neurovascular Devices Market
- 8.3.1. U.S. Neurovascular Devices Market
  - 8.3.1.1. Type breakdown size & forecasts, 2025-2035
  - 8.3.1.2. Application breakdown size & forecasts, 2025-2035
  - 8.3.1.3. End User breakdown size & forecasts, 2025-2035
- 8.3.2. Canada Neurovascular Devices Market
  - 8.3.2.1. Type breakdown size & forecasts, 2025-2035
  - 8.3.2.2. Application breakdown size & forecasts, 2025-2035
  - 8.3.2.3. End User breakdown size & forecasts, 2025-2035
8.4. Europe Neurovascular Devices Market
- 8.4.1. UK Neurovascular Devices Market
  - 8.4.1.1. Type breakdown size & forecasts, 2025-2035
  - 8.4.1.2. Application breakdown size & forecasts, 2025-2035
  - 8.4.1.3. End User breakdown size & forecasts, 2025-2035
- 8.4.2. Germany Neurovascular Devices Market
  - 8.4.2.1. Type breakdown size & forecasts, 2025-2035
  - 8.4.2.2. Application breakdown size & forecasts, 2025-2035
  - 8.4.2.3. End User breakdown size & forecasts, 2025-2035
- 8.4.3. France Neurovascular Devices Market
  - 8.4.3.1. Type breakdown size & forecasts, 2025-2035
  - 8.4.3.2. Application breakdown size & forecasts, 2025-2035
  - 8.4.3.3. End User breakdown size & forecasts, 2025-2035
- 8.4.4. Spain Neurovascular Devices Market
  - 8.4.4.1. Type breakdown size & forecasts, 2025-2035
  - 8.4.4.2. Application breakdown size & forecasts, 2025-2035
  - 8.4.4.3. End User breakdown size & forecasts, 2025-2035
- 8.4.5. Italy Neurovascular Devices Market
  - 8.4.5.1. Type breakdown size & forecasts, 2025-2035
  - 8.4.5.2. Application breakdown size & forecasts, 2025-2035
  - 8.4.5.3. End User breakdown size & forecasts, 2025-2035
- 8.4.6. Rest of Europe Neurovascular Devices Market
  - 8.4.6.1. Type breakdown size & forecasts, 2025-2035
  - 8.4.6.2. Application breakdown size & forecasts, 2025-2035
  - 8.4.6.3. End User breakdown size & forecasts, 2025-2035
8.5. Asia Pacific Neurovascular Devices Market
- 8.5.1. China Neurovascular Devices Market
  - 8.5.1.1. Type breakdown size & forecasts, 2025-2035
  - 8.5.1.2. Application breakdown size & forecasts, 2025-2035
  - 8.5.1.3. End User breakdown size & forecasts, 2025-2035
- 8.5.2. India Neurovascular Devices Market
  - 8.5.2.1. Type breakdown size & forecasts, 2025-2035
  - 8.5.2.2. Application breakdown size & forecasts, 2025-2035
  - 8.5.2.3. End User breakdown size & forecasts, 2025-2035
- 8.5.3. Japan Neurovascular Devices Market
  - 8.5.3.1. Type breakdown size & forecasts, 2025-2035
  - 8.5.3.2. Application breakdown size & forecasts, 2025-2035
  - 8.5.3.3. End User breakdown size & forecasts, 2025-2035
- 8.5.4. Australia Neurovascular Devices Market
  - 8.5.4.1. Type breakdown size & forecasts, 2025-2035
  - 8.5.4.2. Application breakdown size & forecasts, 2025-2035
  - 8.5.4.3. End User breakdown size & forecasts, 2025-2035
- 8.5.5. South Korea Neurovascular Devices Market
  - 8.5.5.1. Type breakdown size & forecasts, 2025-2035
  - 8.5.5.2. Application breakdown size & forecasts, 2025-2035
  - 8.5.5.3. End User breakdown size & forecasts, 2025-2035
- 8.5.6. Rest of APAC Neurovascular Devices Market
  - 8.5.6.1. Type breakdown size & forecasts, 2025-2035
  - 8.5.6.2. Application breakdown size & forecasts, 2025-2035
  - 8.5.6.3. End User breakdown size & forecasts, 2025-2035
8.6. Latin America Neurovascular Devices Market
- 8.6.1. Brazil Neurovascular Devices Market
  - 8.6.1.1. Type breakdown size & forecasts, 2025-2035
  - 8.6.1.2. Application breakdown size & forecasts, 2025-2035
  - 8.6.1.3. End User breakdown size & forecasts, 2025-2035
- 8.6.2. Mexico Neurovascular Devices Market
  - 8.6.2.1. Type breakdown size & forecasts, 2025-2035
  - 8.6.2.2. Application breakdown size & forecasts, 2025-2035
  - 8.6.2.3. End User breakdown size & forecasts, 2025-2035
8.7. Middle East and Africa Neurovascular Devices Market
- 8.7.1. UAE Neurovascular Devices Market
  - 8.7.1.1. Type breakdown size & forecasts, 2025-2035
  - 8.7.1.2. Application breakdown size & forecasts, 2025-2035
  - 8.7.1.3. End User breakdown size & forecasts, 2025-2035
- 8.7.2. Saudi Arabia (KSA) Neurovascular Devices Market
  - 8.7.2.1. Type breakdown size & forecasts, 2025-2035
  - 8.7.2.2. Application breakdown size & forecasts, 2025-2035
  - 8.7.2.3. End User breakdown size & forecasts, 2025-2035
- 8.7.3. South Africa Neurovascular Devices Market
  - 8.7.3.1. Type breakdown size & forecasts, 2025-2035
  - 8.7.3.2. Application breakdown size & forecasts, 2025-2035
  - 8.7.3.3. End User breakdown size & forecasts, 2025-2035

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Medtronic plc
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Financial Performance (Subject to Data Availability)
- 9.2.5. Product/Services Port
- 9.2.6. Recent Development
- 9.2.7. Market Strategies
- 9.2.8. SWOT Analysis
9.3. Stryker Corporation
9.4. Boston Scientific Corporation
9.5. Johnson & Johnson (Cerenovus)
9.6. Terumo Corporation
9.7. Penumbra, Inc.
9.8. MicroVention, Inc.
9.9. Cook Medical
9.10. Merit Medical Systems, Inc.
9.11. Integra LifeSciences Holdings Corporation
9.12. Balt Group
9.13. Rapid Medical
9.14. Phenox GmbH
9.15. W. L. Gore & Associates, Inc.
9.16. Lepu Medical Technology Co., Ltd.